Zamicastat

CAS : 1080028-80-3

Ref. 3D-FTB02880

Informations sur le produit

• Nom: Zamicastat
• Synonymes: 1-[(3R)-6,8-Difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-2H-imidazole-2-thione, 2H-Imidazole-2-thione, 1-[(3R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-yl]-1,3-dihydro-5-[2-[(phenylmethyl)amino]ethyl]-, (R)-5-(2-(Benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1H-imidazole-2(3H)-thione

Description

Zamicastat is a drug that is used in the treatment of vascular dementia, including multi-infarct dementia and Alzheimer's disease. It has been shown to reduce systolic pressure and improve clinical response in patients with congestive heart failure. Zamicastat inhibits the production of dopamine β-hydroxylase, which is an enzyme that catalyzes the conversion of dopamine to norepinephrine. It also inhibits the production of chemoattractant protein, an inflammatory mediator. This drug is being investigated as a possible diagnostic agent for cardiac hypertrophy and sildenafil for the treatment of erectile dysfunction.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 401.5 g/mol
• Formule: C₂₁H₂₁F₂N₃OS
• Degré de pureté: Min. 95%